Adaptimmune Therapeutics: Q4 Earnings Insights

Adaptimmune Therapeutics ADAP reported its Q4 earnings results on Monday, March 14, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Adaptimmune Therapeutics missed estimated earnings by 128.57%, reporting an EPS of $-0.04 versus an estimate of $0.14.

Revenue was down $85.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 4.19% increase in the share price the next day.

Here's a look at Adaptimmune Therapeutics's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.